logo
Morgans Keeps Their Buy Rating on Microba Life Sciences Limited (MAP)

Morgans Keeps Their Buy Rating on Microba Life Sciences Limited (MAP)

In a report released today, Iain Wilkie from Morgans maintained a Buy rating on Microba Life Sciences Limited (MAP – Research Report), with a price target of A$0.32.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
According to TipRanks, Wilkie is an analyst with an average return of -11.3% and a 29.69% success rate. Wilkie covers the Healthcare sector, focusing on stocks such as Nanosonics Limited, Pro Medicus Limited, and Mach7 Technologies.
Currently, the analyst consensus on Microba Life Sciences Limited is a Moderate Buy with an average price target of A$0.35.
The company has a one-year high of A$0.33 and a one-year low of A$0.15. Currently, Microba Life Sciences Limited has an average volume of 180.3K.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store